Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nina B. Stærke"'
Autor:
Eva A.M. Baerends, Astrid K. Hvidt, Joanne Reekie, Ole S. Søgaard, Nina B. Stærke, Dorthe Raben, Henrik Nielsen, Kristine T. Petersen, Maria R. Juhl, Isik S. Johansen, Susan O. Lindvig, Lone W. Madsen, Lothar Wiese, Lene S. Knudsen, Mette B. Iversen, Thomas Benfield, Kasper K. Iversen, Sidsel D. Andersen, Anna K. Juhl, Lisa L. Dietz, Signe R. Andreasen, Thea K. Fischer, Christian Erikstrup, Palle Valentiner-Branth, Jens Lundgren, Lars Østergaard, Martin Tolstrup, J. Lundgren, L. Østergaard, T. Benfield, L. Krohn-Dehli, D.K. Petersen, K. Fogh, E. Højmark, K.K. Iversen, P. Bek, V. Klastrup, F. Larsen, S.H. Rasmussen, M.H. Schleimann, S. Schieber, N.B. Stærke, A. Søndergaard, B. Tarp, M. Tousgaard, Y. Yehdego, J. Bodilsen, H. Nielsen, K.T. Petersen, M. Ruwald, R.K. Thisted, S.F. Caspersen, M. Iversen, L.S. Knudsen, J.L. Meyerhoff, L.G. Sander, L. Wiese, C. Abildgaard, I.K. Holden, N.E. Johansen, I.S. Johansen, L. Larsen, S.O. Lindvig, L.W. Madsen, A. Øvrehus, N.A. Kruse, H. Lomholdt, T.G. Krause, P. Valentiner-Branth, B. Søborg, T.K. Fischer, C. Erikstrup, S.R. Ostrowski, M. Tolstrup, O.S. Søgaard, D. Raben, E. Jylling, D. Hougaard, S.D. Andersen, K. Lykkegaard, S.R. Andreasen, E. Baerends, L.L. Dietz, A.K. Hvidt, A.K. Juhl, R. Olesen, K.K. Andersen, W. Bannister, C. Bjernved, T.W. Elsing, F.V. Esmann, M.A. Ghafari, E. Gravholdt, S.F. Jakobsen, M.L. Jakobsen, C.M. Jensen, T.Ø. Jensen, D. Kristensen, L.R. Kumar, C. Matthews, N. Normand, C. Olsson, J. Reekie, A. Traytel, T. Weide, A.M. Hvas, H. Støvring
Publikováno v:
iScience, Vol 26, Iss 9, Pp 107621- (2023)
Summary: SARS-CoV-2 Omicron quickly spread globally, also in regions with high vaccination coverage, emphasizing the importance of exploring the immunological requirements for protection against Omicron breakthrough infection.The test-negative matche
Externí odkaz:
https://doaj.org/article/ea485062804846ef9b467b59eb882465
Autor:
Astrid K. Hvidt, Eva A. M. Baerends, Ole S. Søgaard, Nina B. Stærke, Dorthe Raben, Joanne Reekie, Henrik Nielsen, Isik S. Johansen, Lothar Wiese, Thomas L. Benfield, Kasper K. Iversen, Ahmed B. Mustafa, Maria R. Juhl, Kristine T. Petersen, Sisse R. Ostrowski, Susan O. Lindvig, Line D. Rasmussen, Marianne H. Schleimann, Sidsel D. Andersen, Anna K. Juhl, Lisa L. Dietz, Signe R. Andreasen, Jens Lundgren, Lars Østergaard, Martin Tolstrup, the ENFORCE Study Group
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
The SARS-CoV-2 pandemic has, as of July 2022, infected more than 550 million people and caused over 6 million deaths across the world. COVID-19 vaccines were quickly developed to protect against severe disease, hospitalization and death. In the prese
Externí odkaz:
https://doaj.org/article/001cb90803124b8e8d8603d1f6f5649d
Autor:
Sisse R. Ostrowski, Ole S. Søgaard, Martin Tolstrup, Nina B. Stærke, Jens Lundgren, Lars Østergaard, Anne-Mette Hvas
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Introduction of vaccines against COVID-19 has provided the most promising chance to control the world-wide COVID-19 pandemic. However, the adenovirus-vector based Oxford/AstraZeneca [ChAdOx1] (AZ) and Johnson & Johnson [Ad26.CoV2.S] COVID-19 vaccines
Externí odkaz:
https://doaj.org/article/07416948d53f4c9593ec0c51db106d79
Autor:
Jesper D. Gunst, Nina B. Staerke, Marie H. Pahus, Lena H. Kristensen, Jacob Bodilsen, Nicolai Lohse, Lars S. Dalgaard, Dorthe Brønnum, Ole Fröbert, Bo Hønge, Isik S. Johansen, Ida Monrad, Christian Erikstrup, Regitze Rosendal, Emil Vilstrup, Theis Mariager, Dorthe G. Bove, Rasmus Offersen, Shakil Shakar, Sara Cajander, Nis P. Jørgensen, Sajitha S. Sritharan, Peter Breining, Søren Jespersen, Klaus L. Mortensen, Mads L. Jensen, Lilian Kolte, Giacomo S. Frattari, Carsten S. Larsen, Merete Storgaard, Lars P. Nielsen, Martin Tolstrup, Eva A. Sædder, Lars J. Østergaard, Hien T.T. Ngo, Morten H. Jensen, Jesper F. Højen, Mads Kjolby, Ole S. Søgaard
Publikováno v:
EClinicalMedicine, Vol 35, Iss , Pp 100849- (2021)
Background: The trans-membrane protease serine 2 (TMPRSS2) is essential for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry and infection. Efficacy and safety of TMPRSS2 inhibitors in patients with coronavirus disease 2019 (Co
Externí odkaz:
https://doaj.org/article/c25557f47802410fa852f84ca0e3b0e0
Autor:
Beate Kampmann, Shabir A. Madhi, Iona Munjal, Eric A.F. Simões, Barbara A. Pahud, Conrado Llapur, Jeffrey Baker, Gonzalo Pérez Marc, David Radley, Emma Shittu, Julia Glanternik, Hasra Snaggs, James Baber, Philip Zachariah, Shaun L. Barnabas, Merlin Fausett, Tyler Adam, Nicole Perreras, Marlies A. Van Houten, Anu Kantele, Li-Min Huang, Louis J. Bont, Takeo Otsuki, Sergio L. Vargas, Joanna Gullam, Bruce Tapiero, Renato T. Stein, Fernando P. Polack, Heather J. Zar, Nina B. Staerke, María Duron Padilla, Peter C. Richmond, Kenneth Koury, Katherine Schneider, Elena V. Kalinina, David Cooper, Kathrin U. Jansen, Annaliesa S. Anderson, Kena A. Swanson, William C. Gruber, Alejandra Gurtman
Publikováno v:
New England Journal of Medicine. 388:1451-1464